NCT00210041

Phase 2 Study of Association Gemcitabine-Cisplatin to Treat Penis Epidermoid Carcinoma

Phase 2 Study for Treatment of Penis Epidermoid Carcinoma Loco-regionally Advanced or Metastatic by Association Gemcitabine-Cisplatin

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 50 (estimated)
• Sponsor: Institut Claudius Regaud · Academic / Other
• Sex: Male
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine whether association Gemcitabine-Cisplatin is effective in the treatment of penis epidermoid carcinoma loco-regionally advanced or metastatic.

Conditions

• Genital Neoplasms, Male

Interventions

Type	Name	Description
DRUG	Gemcitabine	Gemzar IV infusion 30 minutes Day 1/ Day 15 1250 mg/m²/j
DRUG	Cisplatin	Cisplatin 50 mg/m²/day 1 h IV infusion at Day 1 / Day 15

Timeline

• Start date: 2004-02-01
• Primary completion: 2011-12-01
• Completion: 2012-12-01
• First posted: 2005-09-21
• Last updated: 2015-03-31

Locations

11 sites across 1 country: France